H.C. Wainwright Reiterates Buy Rating on CG Oncology (CGON)

December 6, 2024 6:45 AM EST Send to a Friend
H.C. Wainwright analyst Andres Maldonado reiterated a Buy rating and $75.00 price target on CG Oncology (NASDAQ: CGON).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login